Deutsch Intern
Department of General Practice

ECRAID-Prime

ECRAID-Prime („European Clinical Research Alliance on Infectious Diseases: Primary Care adaptive platform trial for pandemics and epidemics“)

ECRAID-Prime is a randomized controlled intervention study that is investigating various active substances for the treatment of respiratory tract infections in adult patients in 6 European countries as part of a platform study.

Respiratory tract infections can be caused by a variety of pathogens, such as the SARS-CoV-2 virus, but also by influenza pathogens and other viruses and, less frequently, bacteria. Especially in the colder months, respiratory tract infections are a frequent cause for consultation in GP practices.

The University Hospital of Würzburg is a study center of the EU-funded research network ECRAID-Prime through the Department of General Medicine. The aim of the study is to find new therapies for respiratory tract infections that can help

  • speed up recovery
  • reduce the severity of symptoms
  • reduce the viral load and thus possibly prevent infection

Recruitment of study participants at the Würzburg site has been completed since March 2026. The data collected is currently being analysed. We would like to thank all participants for their valuable contribution to further research into respiratory tract infections!